The University of Arizona Center for Innovation (UACI) is pleased to announce the winning startup of the UACI-sponsored launch competition fueled by the Bioindustry Organization of Southern Arizona (BIOSA). TheraCea Pharma will receive a sponsored year’s admission at the new biotech incubator, UACI at Oro Valley. Included with entrance into the program and space at the new location, the startup will also be awarded a cash prize of $5,000.
Audiologist and molecular biologist O’neil Guthrie, an associate professor in Northern Arizona University’s Department of Communication Sciences and Disorders, is collaborating with New Jersey-based Optigenex to conduct a pre-clinical investigation to help the body’s natural ability to repair DNA through
a novel therapy.
On the heels of a study showing how cancer can be precisely detected by a liquid biopsy blood test created by the Translational Genomics Research Institute (TGen), a new $2.1 million federal grant will enable TGen and Mayo Clinic researchers to fine-tune the system in clinical trials.
Scientists develop new approach to treat wounds by using three-dimensional skin substitutes formed from native skin proteins through a process called electrospinning. Shifting from using synthetic materials, electrospun
protein scaffolds guide cell adhesion and growth, and can be used to deliver cells, drugs and even genes into the body.
Health officials from the World Health Organization (WHO) and National Institutes of Health (NIH) announced that four antidotes— including one first developed by Arizona State University and its commercial partners—had been tested in the largest Ebola clinical trial to date that’s shown it can overcome the virus and save lives.
Rosalind Sadleir, an associate professor of biomedical engineering in the Ira A. Fulton Schools of Engineering at Arizona State University, is working to measure electrical properties of different types of tissue to better capture what’s happening in the body and better diagnose patients.
Researchers have found that a gene known as AEBP1 may play a central role in the development, severity and potential treatment of liver disease
A new type of blood test for breast cancer could help avoid thousands of unnecessary surgeries and otherwise precisely monitor disease progression
While family history has previously been associated with the risk of Alzheimer’s, this is the first study of its kind that in these numbers indicates the risk can be detected up to four decades before the typical age of onset.
Whether you use the word biotechnology, bioscience or one of a number of related words—the lines are quickly blurring—“bio” in Arizona has made a major impact as it has taken root in our state.